A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol

Abstract Background Coronavirus disease 2019 (COVID-19) results in debilitating long-term symptoms, often referred to as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), in a substantial subgroup of patients. One of the most prevalent symptoms following COVID-19 is severe fatigue. Prompt delivery...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	T. A. Kuut, F. Müller, A. Aldenkamp, E. Assmann-Schuilwerve, A. Braamse, S. E. Geerlings, K. B. Gibney, R. A. A. Kanaan, P. Nieuwkerk, T. C. Olde Hartman, D. Pauëlsen, M. Prins, K. Slieker, M. Van Vugt, C. P. Bleeker-Rovers, S. P. Keijmel, H. Knoop
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Cognitive behavioural therapy COVID-19 Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Post-COVID-19 syndrome Long COVID Long-Haul COVID-19 Fatigue Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c75c9f4e9f324d1aa334ace51d1aac03
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c75c9f4e9f324d1aa334ace51d1aac03
record_format	dspace
spelling	oai:doaj.org-article:c75c9f4e9f324d1aa334ace51d1aac032021-12-05T12:19:58ZA randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol10.1186/s13063-021-05569-y1745-6215https://doaj.org/article/c75c9f4e9f324d1aa334ace51d1aac032021-12-01T00:00:00Zhttps://doi.org/10.1186/s13063-021-05569-yhttps://doaj.org/toc/1745-6215Abstract Background Coronavirus disease 2019 (COVID-19) results in debilitating long-term symptoms, often referred to as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), in a substantial subgroup of patients. One of the most prevalent symptoms following COVID-19 is severe fatigue. Prompt delivery of cognitive behavioural therapy (CBT), an evidence-based treatment that has shown benefit in reducing severe fatigue in other conditions, may reduce post-COVID-19 fatigue. Based on an existing CBT protocol, a blended intervention of 17 weeks, Fit after COVID, was developed to treat severe fatigue after the acute phase of infection with SARS-CoV-2. Method The ReCOVer study is a multicentre 2-arm randomised controlled trial (RCT) to test the efficacy of Fit after COVID on severe post-infectious fatigue. Participants are eligible if they report severe fatigue 3 up to and including 12 months following COVID-19. One hundred and fourteen participants will be randomised to either Fit after COVID or care as usual (ratio 1:1). The primary outcome, the fatigue severity subscale of the Checklist Individual Strength (CIS-fatigue), is assessed in both groups before randomisation (T0), directly post CBT or following care as usual (T1), and at follow-up 6 months after the second assessment (T2). In addition, a long-term follow-up (T3), 12 months after the second assessment, is performed in the CBT group only. The primary objective is to investigate whether CBT will lead to a significantly lower mean fatigue severity score measured with the CIS-fatigue across the first two follow-up assessments (T1 and T2) as compared to care as usual. Secondary objectives are to determine the proportion of participants no longer being severely fatigued (operationalised in different ways) at T1 and T2 and to investigate changes in physical and social functioning, in the number and severity of somatic symptoms and in problems concentrating across T1 and T2. Discussion This is the first trial testing a cognitive behavioural intervention targeting severe fatigue after COVID-19. If Fit after COVID is effective in reducing fatigue severity following COVID-19, this intervention could contribute to alleviating the long-term health consequences of COVID-19 by relieving one of its most prevalent and distressing long-term symptoms. Trial registration Netherlands Trial Register NL8947 . Registered on 14 October 2020.T. A. KuutF. MüllerA. AldenkampE. Assmann-SchuilwerveA. BraamseS. E. GeerlingsK. B. GibneyR. A. A. KanaanP. NieuwkerkT. C. Olde HartmanD. PauëlsenM. PrinsK. SliekerM. Van VugtC. P. Bleeker-RoversS. P. KeijmelH. KnoopBMCarticleCognitive behavioural therapyCOVID-19Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)Post-COVID-19 syndromeLong COVIDLong-Haul COVID-19 FatigueMedicine (General)R5-920ENTrials, Vol 22, Iss 1, Pp 1-15 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Cognitive behavioural therapy COVID-19 Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Post-COVID-19 syndrome Long COVID Long-Haul COVID-19 Fatigue Medicine (General) R5-920
spellingShingle	Cognitive behavioural therapy COVID-19 Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Post-COVID-19 syndrome Long COVID Long-Haul COVID-19 Fatigue Medicine (General) R5-920 T. A. Kuut F. Müller A. Aldenkamp E. Assmann-Schuilwerve A. Braamse S. E. Geerlings K. B. Gibney R. A. A. Kanaan P. Nieuwkerk T. C. Olde Hartman D. Pauëlsen M. Prins K. Slieker M. Van Vugt C. P. Bleeker-Rovers S. P. Keijmel H. Knoop A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
description	Abstract Background Coronavirus disease 2019 (COVID-19) results in debilitating long-term symptoms, often referred to as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), in a substantial subgroup of patients. One of the most prevalent symptoms following COVID-19 is severe fatigue. Prompt delivery of cognitive behavioural therapy (CBT), an evidence-based treatment that has shown benefit in reducing severe fatigue in other conditions, may reduce post-COVID-19 fatigue. Based on an existing CBT protocol, a blended intervention of 17 weeks, Fit after COVID, was developed to treat severe fatigue after the acute phase of infection with SARS-CoV-2. Method The ReCOVer study is a multicentre 2-arm randomised controlled trial (RCT) to test the efficacy of Fit after COVID on severe post-infectious fatigue. Participants are eligible if they report severe fatigue 3 up to and including 12 months following COVID-19. One hundred and fourteen participants will be randomised to either Fit after COVID or care as usual (ratio 1:1). The primary outcome, the fatigue severity subscale of the Checklist Individual Strength (CIS-fatigue), is assessed in both groups before randomisation (T0), directly post CBT or following care as usual (T1), and at follow-up 6 months after the second assessment (T2). In addition, a long-term follow-up (T3), 12 months after the second assessment, is performed in the CBT group only. The primary objective is to investigate whether CBT will lead to a significantly lower mean fatigue severity score measured with the CIS-fatigue across the first two follow-up assessments (T1 and T2) as compared to care as usual. Secondary objectives are to determine the proportion of participants no longer being severely fatigued (operationalised in different ways) at T1 and T2 and to investigate changes in physical and social functioning, in the number and severity of somatic symptoms and in problems concentrating across T1 and T2. Discussion This is the first trial testing a cognitive behavioural intervention targeting severe fatigue after COVID-19. If Fit after COVID is effective in reducing fatigue severity following COVID-19, this intervention could contribute to alleviating the long-term health consequences of COVID-19 by relieving one of its most prevalent and distressing long-term symptoms. Trial registration Netherlands Trial Register NL8947 . Registered on 14 October 2020.
format	article
author	T. A. Kuut F. Müller A. Aldenkamp E. Assmann-Schuilwerve A. Braamse S. E. Geerlings K. B. Gibney R. A. A. Kanaan P. Nieuwkerk T. C. Olde Hartman D. Pauëlsen M. Prins K. Slieker M. Van Vugt C. P. Bleeker-Rovers S. P. Keijmel H. Knoop
author_facet	T. A. Kuut F. Müller A. Aldenkamp E. Assmann-Schuilwerve A. Braamse S. E. Geerlings K. B. Gibney R. A. A. Kanaan P. Nieuwkerk T. C. Olde Hartman D. Pauëlsen M. Prins K. Slieker M. Van Vugt C. P. Bleeker-Rovers S. P. Keijmel H. Knoop
author_sort	T. A. Kuut
title	A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
title_short	A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
title_full	A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
title_fullStr	A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
title_full_unstemmed	A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol
title_sort	randomised controlled trial testing the efficacy of fit after covid, a cognitive behavioural therapy targeting severe post-infectious fatigue following covid-19 (recover): study protocol
publisher	BMC
publishDate	2021
url	https://doaj.org/article/c75c9f4e9f324d1aa334ace51d1aac03
work_keys_str_mv	AT takuut arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT fmuller arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT aaldenkamp arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT eassmannschuilwerve arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT abraamse arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT segeerlings arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT kbgibney arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT raakanaan arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT pnieuwkerk arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT tcoldehartman arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT dpauelsen arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT mprins arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT kslieker arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT mvanvugt arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT cpbleekerrovers arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT spkeijmel arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT hknoop arandomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT takuut randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT fmuller randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT aaldenkamp randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT eassmannschuilwerve randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT abraamse randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT segeerlings randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT kbgibney randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT raakanaan randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT pnieuwkerk randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT tcoldehartman randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT dpauelsen randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT mprins randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT kslieker randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT mvanvugt randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT cpbleekerrovers randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT spkeijmel randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol AT hknoop randomisedcontrolledtrialtestingtheefficacyoffitaftercovidacognitivebehaviouraltherapytargetingseverepostinfectiousfatiguefollowingcovid19recoverstudyprotocol
_version_	1718372041605775360

A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol

Ejemplares similares